Revision history of "Earlier medical knowledge about AZD4831 a novel myeloperoxidase inhibitor produced for people with cardiovascular failing using conserved ejection portion"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 09:59, 17 May 2024‎ Branchsailor7 (Talk | contribs)‎ . . (3,666 bytes) (+3,666)‎ . . (Created page with "04). Individuals acquiring IVT ahead of transfer got greater chances of three-month reduced handicap (typical OR=1.Before 2000; 95%CI1.17-3.Thirty five), exceptional (OR=1.Sev...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=Earlier_medical_knowledge_about_AZD4831_a_novel_myeloperoxidase_inhibitor_produced_for_people_with_cardiovascular_failing_using_conserved_ejection_portion"